PLINAZOLIN
Commercial- Indications
- Insect control
Company intelligence / Profile preview
Syngenta
Basel, Switzerlandsyngenta.com ↗
- Ownership
- Private
- Employees
- ~56000
- Development stage
- Commercial
01
Overview
Syngenta develops and markets commercialized crop protection products—including herbicides, fungicides, insecticides—and seeds with advanced genetic traits. It has a global commercial presence with no clinical pipeline as understood in pharma/biotech.
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologicGenetically modified organism (GMO) seeds and traitsDigital agriculture platforms
- Industry
- Agriculture & AgTech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Collaborations with academic institutions such as Queensland University for biofuels researchPunjab Agricultural University for rice productivitypartnerships with Myriad Genetics Inc., among others
Beyond the preview
Go deeper on Syngenta.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Syngenta.